IgY-technology for sustainable development: A policy brief

Carlos Leonidas Leiva, Florencia Martino, Clovis Freire, Pablo Chacana

Research output: Unpublished contribution to conferenceUnpublished paper

45 Downloads (Pure)


IgY-technology (the production and extraction of specific IgY antibodies from egg yolk) is an innovative method to produce antibodies for therapy and prophylaxis. Many research groups have demonstrated that IgY is active against several pathogens or conditions, a fact that may support the design of novel, safe and effective health products. In fact, IgY-technology not only targets SDG 3 (Good health and well-being) but also SDG 9 (Industry, innovation, and infrastructure) and 17 (Partnerships for the goals) which offers an opportunity for developing countries to tackle current and future health challenges. Therefore, the aim of this policy brief is to provide an outline of empirical facts as well as a prospective work related to IgY-technology and the oral administration of egg yolk antibodies as prophylaxis and therapy in a wide range of infectious and non-communicable diseases.
Original languageEnglish
Number of pages7
Publication statusPublished - 3 May 2023
Event8th Multi-stakeholder Forum on Science, Technology and Innovation for the Sustainable Development Goals - United Nations Headquarters, New York City, United States
Duration: 3 May 20234 May 2023


Conference8th Multi-stakeholder Forum on Science, Technology and Innovation for the Sustainable Development Goals
Abbreviated title STI Forum
Country/TerritoryUnited States
CityNew York City
Internet address


Dive into the research topics of 'IgY-technology for sustainable development: A policy brief'. Together they form a unique fingerprint.
  • IgY industries and markets

    Vieira-Pires, R. S., Ahn, H. C., Bok, M., Caulfield, C. D., Chacana, P., Elahi, F., Larsson, A. O., Leiva, C. L., Moran, L. M., Morgan, P. M., Parreño, V., Vega, C. G. & Wigdorovitz, A., 24 Jun 2021, IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice. Springer International Publishing, p. 279-308 30 p.

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    3 Citations (Scopus)
  • IgY-technology (egg yolk antibodies) in human medicine: A review of patents and clinical trials

    Leiva, C. L., Gallardo, J., Casanova, N., Terzolo, H. & Chacana, P., Apr 2020, In: International Immunopharmacology. 81, p. 106269 106269.

    Research output: Contribution to journalArticlepeer-review

    44 Citations (Scopus)

Cite this